Skip to content

Effect of TECAR Therapy on Pain, Balance, and Quality of Life in Elderly Men With Knee Osteoarthritis

Effect of TECAR Therapy on Pain, Balance, and Quality of Life in Elderly Men With Knee Osteoarthritis: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07633795
Enrollment
80
Registered
2026-06-08
Start date
2026-06-15
Completion date
2026-10-18
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

Evaluate the effect of TECAR therapy combined with traditional physiotherapy on pain, balance, and quality of life in elderly men with knee osteoarthritis .

Detailed description

Eighty elderly men diagnosed with knee osteoarthritis will be recruited from physical therapy and orthopedic outpatient clinics. Following a baseline screening, patients will be randomly assigned into two parallel groups: The Study Group: Will include 40 men participating in true TECAR therapy plus a standardized traditional physiotherapy program for 8 weeks. The Control Group: Will include 40 men participating in sham TECAR therapy plus the same traditional physiotherapy program for 8 weeks.

Interventions

DEVICETrue TECAR Therapy

20 minutes per session (10 mins capacitive mode, 10 mins resistive mode), 3 sessions per week for 8 weeks will be applied around the affected knee joint. Thermal delivery will be adjusted to a comfortable, non-painful warm sensation

The device will be applied using identical electrode placement, application time, and interface screen indicators, but with the power output disabled so that no current or deep thermal energy is transferred to the tissues.

OTHERTraditional Physiotherapy

Standardized knee osteoarthritis rehabilitation including progressive quad/hamstring strengthening, hip abductor strengthening, range of motion exercises, and flexibility training

Sponsors

Middle East University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
65 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Clinical and radiographic diagnosis of mild and moderate bilateral or unilateral knee osteoarthritis meeting the American College of Rheumatology (ACR) criteria. * Presence of chronic knee pain lasting for more than 6 months. * Ability to ambulate independently with or without an assistive device.

Exclusion criteria

* Severe knee osteoarthritis (grade IV) requiring imminent surgical joint replacement. * History of previous knee arthroplasty, internal fixation, or significant trauma to the affected lower extremity. * Presence of pacemakers, metallic implants in the knee region, or severe. - peripheral vascular disease (absolute contraindications for TECAR therapy). * Intra-articular injections (corticosteroids, platelet-rich plasma, or hyaluronic acid) into the knee within the past 3 months. * Cognitive impairment or systemic inflammatory conditions (e.g., rheumatoid arthritis).

Design outcomes

Primary

MeasureTime frameDescription
Pain IntensityBaseline and after 8 weeksVisual Analog Scale will be used to assess pain intensity

Secondary

MeasureTime frameDescription
BalanceBaseline and after 8 weeksBerg Balance Scale will be used to assess balance
Health-Related Quality of LifeBaseline and after 8 weeksShort Form-12 Health Survey (SF-12) will be used to assess quality of life

Contacts

CONTACTSaher Lotfy Elgayar, Ph.D
saherlotfy020@gmail.com+201020429911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026